default author photo

David Spirk

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

34

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Optimized Treatment of Refractory Hypercholesterolemia in Patients with Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia with Alirocumab (OPTIMIZE)

Number of pages: 27 Posted: 07 Feb 2022
Isabella Sudano, François Mach, Tiziano Moccetti, Thilo Burkard, Christian Fahe, Alain Delabays, Hans Rickli, Pierre-Frédéric Keller, Jörn Dopheide, Sereina Bodenmann, Tom Fiolka, Georg Ehret and David Spirk
University Heart Centre, University of Geneva - Geneva University Hospitals, affiliation not provided to SSRN, University of Basel - University Hospital Basel, affiliation not provided to SSRN, affiliation not provided to SSRN, Kantonsspital St Gallen, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 34 (1,277,121)

Abstract:

Loading...

Atherosclerotic cardiovascular disease, heterozygous familial hypercholesterolemia, LDL-C target attainment, PCSK9 inhibition, statin intolerance